GHRS
GHRS
NASDAQ · Pharmaceuticals

Gh Research Plc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$30.27
-0.37 (-1.21%)
As of Aug 9, 10:14 PM ET ·
GHRS News2 articles
AtaiBeckley Merger Value Reflects 14% of CVR Face Value
AtaiBeckley shares trade at $7.091, 34 cents above Eli Lilly's cash offer, implying a CVR value of 13.6% of its maximum $2.50 face value.
Markets
AtaiBeckley Soars on Lilly Deal; Market Weighs Milestone Value
AtaiBeckley shares surged 31% to $7.04 after Eli Lilly agreed to acquire the company for up to $9.25 per share, including contingent payments. The stock sits just $0.29 above the cash offer, reflecting cautious market expectations for milestones.
Markets